Clinical Trials Logo

Clinical Trial Summary

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease


Clinical Trial Description

A Randomized, Double-blind, Placebo-controlled, Parallel-designed Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Subjects with Stable Coronary Heart Disease ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03351738
Study type Interventional
Source MedImmune LLC
Contact
Status Active, not recruiting
Phase Phase 2
Start date December 13, 2017
Completion date August 10, 2018